LKFT

Lakefront Biotherapeutics N.V.

Investor Moves

NameValueActionChangePriceCurrent Price
Steven CohenPoint72
$10.0M332.1k shares
TrimQ1 2026
$5.9M
$30.00
$27.73
Ken GriffinCitadel Advisors
$-3.5M
ExitQ1 2026
$3.5M
--
$27.73
Jim SimonsRenaissance Technologies
$9.5M315.4k shares
TrimQ1 2026
$695k
$30.00
$27.73
Steven CohenPoint72
$16M486.2k shares
ExitQ4 2025
$15M
$32.70
$27.73
Jim SimonsRenaissance Technologies
$10M310.6k shares
ExitQ4 2025
$12M
$32.70
$27.73
Ken GriffinCitadel Advisors
$3.5M108.2k shares
AddQ4 2025
$2.2M
$32.70
$27.73

News

globenewswire.comAcquisition of Own Sharesglobenewswire.comJun 16globenewswire.comLakefront Announces Initiation of €50 Million Stock Repurchase Programglobenewswire.comJun 9globenewswire.comLakefront Appoints Eric Hedrick, MD, as Chief Medical Officerglobenewswire.comJun 8